NAB Shares Hit Record High as First-Quarter Cash Earnings Jump 16% 
Texas Attorney General Ken Paxton Sues Sanofi Over Alleged Healthcare Bribery Scheme 
Microsoft Responds to ICE Surveillance Concerns Amid Azure Cloud Expansion 
OpenAI Nears $100 Billion Funding Round at $850 Billion Valuation: Bloomberg Report 
Qualcomm to Invest $150 Million in India AI Startups, Strengthening Presence in Growing Market 
Mark Zuckerberg Testifies in Youth Social Media Addiction Trial Over Instagram Policies 
Airbus Cuts Jet Production Target Amid Pratt & Whitney Engine Shortages, Q4 Profit Jumps 17% 
Amazon Surpasses Walmart in Annual Revenue, Signaling a New Era in Retail Competition 
Citigroup Private Bank Appoints Chad Reddy as West Market Executive in North America 
Stock Market Movers: NVIDIA and Meta Expand AI Partnership as Cadence Surges on Earnings 
YouTube Outage Disrupts Thousands Worldwide as Recommendation System Fails 
Boeing Secures 50 737 MAX Jet Order from Vietnam Airlines Amid Expanding Global Demand 
Vietnam Airlines, Vietjet, and Sun PhuQuoc Airways Sign Major Boeing Aircraft Deals Amid U.S.–Vietnam Trade Talks 
Medical Groups Sue FTC Over Gender-Affirming Care Investigations Amid Trump Policy Dispute 
TEANECK, N.J., May 07, 2018 -- The Board of Directors of Phibro Animal Health Corporation (Nasdaq:PAHC) today declared a quarterly cash dividend of $0.10 per share on its Class A common stock and Class B common stock, payable on June 27, 2018, to stockholders of record at the close of business on June 6, 2018.
About Phibro Animal Health Corporation
Phibro Animal Health Corporation is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for use in the production of poultry, swine, cattle, dairy and aquaculture. For further information, please visit www.pahc.com.
Contact:
Richard Johnson
Chief Financial Officer, Phibro Animal Health Corporation
+1 201-329-7300
[email protected]
